{"id":432867,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2017-02-10] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:03:51.670000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-12.html?wbdisable=true","snippet":"Notice - Prescription Drug List (PDL): Multiple additions February 10, 2017 Our file number: 17-101580-125 Prescription Drug List (PDL): Multiple additions The purpose of this Notice of Amendment is to notify the additions of Apomorphine hydrochloride, Daclizumab beta, Edoxoban,…","rawSnapshotUrl":"/api/snapshots/raw/432867","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090351/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-12.html?wbdisable=true#ha_snapshot=432867","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}